您的购物车当前为空
SOR-C13 TFA,一种羧基末端截短肽,是一种高亲和力的 TRPV6拮抗剂,IC50值为 14 nM。TRPV6 是一种非电压门控钙通道,与乳腺癌的恶性肿瘤和预后不良有关。SOR-C13 TFA 具有抗癌活性。
SOR-C13 TFA,一种羧基末端截短肽,是一种高亲和力的 TRPV6拮抗剂,IC50值为 14 nM。TRPV6 是一种非电压门控钙通道,与乳腺癌的恶性肿瘤和预后不良有关。SOR-C13 TFA 具有抗癌活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SOR-C13 TFA 相关产品
| 产品描述 | SOR-C13 TFA, a truncated carboxy-terminal peptide, serves as a potent TRPV6 antagonist, demonstrating high affinity with an IC 50 value of 14 nM. TRPV6, a non-voltage-gated calcium channel linked to malignancy and poor prognosis in breast cancer, is effectively targeted by SOR-C13 TFA, indicating its anticancer activity [1]. |
| 靶点活性 | TRPV6:14 nM |
| 分子量 | 1679.84 |
| 分子式 | C74H117F3N20O21 |
| Sequence | Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg |
| Sequence Short | KEFLHPSKVDLPR |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容